Bank of New York Mellon’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.24M | Buy |
358,371
+28,466
| +9% | +$98.5K | ﹤0.01% | 2993 |
|
|
2025
Q1 | $864K | Buy |
329,905
+1,008
| +0.3% | +$2.64K | ﹤0.01% | 3132 |
|
|
2024
Q4 | $1.36M | Buy |
328,897
+50,190
| +18% | +$207K | ﹤0.01% | 2944 |
|
|
2024
Q3 | $1.97M | Sell |
278,707
-75,960
| -21% | -$538K | ﹤0.01% | 2745 |
|
|
2024
Q2 | $2.31M | Buy |
354,667
+48,219
| +16% | +$314K | ﹤0.01% | 2718 |
|
|
2024
Q1 | $2.54M | Sell |
306,448
-15,613
| -5% | -$130K | ﹤0.01% | 2643 |
|
|
2023
Q4 | $3.55M | Sell |
322,061
-459
| -0.1% | -$5.05K | ﹤0.01% | 2538 |
|
|
2023
Q3 | $2.71M | Buy |
322,520
+759
| +0.2% | +$6.38K | ﹤0.01% | 2637 |
|
|
2023
Q2 | $4.04M | Sell |
321,761
-54,240
| -14% | -$681K | ﹤0.01% | 2438 |
|
|
2023
Q1 | $6.19M | Sell |
376,001
-12,484
| -3% | -$206K | ﹤0.01% | 2184 |
|
|
2022
Q4 | $5.8M | Buy |
388,485
+46,233
| +14% | +$691K | ﹤0.01% | 2253 |
|
|
2022
Q3 | $7.66M | Buy |
342,252
+44,636
| +15% | +$998K | ﹤0.01% | 2061 |
|
|
2022
Q2 | $4.99M | Buy |
297,616
+10,730
| +4% | +$180K | ﹤0.01% | 2302 |
|
|
2022
Q1 | $8.59M | Buy |
286,886
+5,958
| +2% | +$178K | ﹤0.01% | 2152 |
|
|
2021
Q4 | $8.63M | Buy |
280,928
+46,046
| +20% | +$1.41M | ﹤0.01% | 2181 |
|
|
2021
Q3 | $7.41M | Buy |
234,882
+67,509
| +40% | +$2.13M | ﹤0.01% | 2285 |
|
|
2021
Q2 | $6.12M | Buy |
167,373
+28,508
| +21% | +$1.04M | ﹤0.01% | 2389 |
|
|
2021
Q1 | $4.8M | Buy |
138,865
+23,011
| +20% | +$796K | ﹤0.01% | 2458 |
|
|
2020
Q4 | $4.81M | Buy |
115,854
+26,801
| +30% | +$1.11M | ﹤0.01% | 2377 |
|
|
2020
Q3 | $3.79M | Buy |
+89,053
| New | +$3.79M | ﹤0.01% | 2361 |
|